Washington, D.C. 20549


Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB Number: 3235-0104
Estimated average burden
hours per response: 0.5
1. Name and Address of Reporting Person*
Krauss Adam

(Last) (First) (Middle)


(City) (State) (Zip)
2. Date of Event Requiring Statement (Month/Day/Year)
3. Issuer Name and Ticker or Trading Symbol
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Chief Legal Officer
5. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year) 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Option (Right to buy) (1) 11/30/2030 Common Stock 75,000 3.7 D
Restricted Stock Units (2) (2) Common Stock 35,000 (2) D
Explanation of Responses:
1. Stock Option awarded in accordance with the Agenus Inc. 2019 Equity Incentive Plan (the "2019 Plan") and vests over four years with one-fourth of the award vesing on each of November 30, 2021, 2022, 2023 and 2024 (provided Mr. Krauss maintains a service relationship with the Company though each such vesting date).
2. Restricted Stock Units awarded in accordance with the 2019 Plan and vest over a three year period with one-third of the award vesting on each of November 30, 2021, 2022 and 2023 (provided Mr. Krauss maintains a service relationship with the Company through each such vesting date).
/s/ Adam Krauss 12/21/2020
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
                               POWER OF ATTORNEY
        For Obtaining EDGAR Access Codes and Executing Forms 3, 4 and 5

     Know all by these presents, that the undersigned hereby constitutes and
appoints each of Garo H. Armen, Christine M. Klaskin, Evan D. Kearns and
Jennifer L. Coffin, signing singly, his/her true and lawful attorney-in-fact to:

     (1)   execute for and on behalf of the undersigned all forms necessary to
           revive or obtain new EDGAR Access Codes for the undersigned,
           including without limitation, PMAC, CCC and passwords necessary to
           enable the undersigned to make filings in the United States
           Securities and Exchange Commission's EDGAR system;

     (2)   execute for and on behalf of the undersigned Forms 3, 4 and 5 in
           accordance with Section 16(a) of the Securities Exchange Act of 1934
           and the rules thereunder, and any other forms or reports the
           undersigned may be required to file, in connection with the
           undersigned's ownership, acquisition, or disposition of securities of
           Agenus Inc., a Delaware corporation;

     (3)   do and perform any and all acts for and on behalf of the undersigned
           which may be necessary or desirable to complete the execution of any
           such Form 3, 4 and 5, or other form or report, complete and execute
           any amendment or amendments thereto, and the timely filing of such
           form with the United States Securities and Exchange Commission and
           any other authority; and

     (4)   take any other action of any type whatsoever in connection with the
           foregoing which, in the opinion of such attorney-in-fact, may be of
           benefit to, in the best interest of, or legally required by, the
           undersigned, it being understood that the documents executed by such
           attorney-in-fact on behalf of the undersigned pursuant to this Power
           of Attorney shall be in such form and shall contain such terms and
           conditions as such attorney-in-fact may approve in his/her

     The undersigned hereby grants to each such attorney-in-fact full power and
authority to do and perform all and every act and thing whatsoever requisite,
necessary and proper to be done in the exercise of any of the rights and powers
herein granted, as fully to all intents and purposes as such attorney-in-fact
might or could do if personally present, with full power of substitution or
revocation, hereby ratifying and confirming all that such attorney-in-fact, or
his/her substitute or substitutes, shall lawfully do or cause to be done by
virtue of this power of attorney and the rights and powers herein granted.  The
undersigned acknowledges that the foregoing attorneys- in-fact, in serving in
such capacity at the request of the undersigned, are not assuming any of the
undersigned's responsibilities to comply with Section 16 of the Securities
Exchange Act of 1934.

     This Power of Attorney shall remain in full force and effect until the
undersigned is no longer required to file Forms 3, 4, and 5 with respect to the
undersigned's holdings of and transactions in securities issued by Agenus Inc.,
unless earlier revoked by the undersigned in a signed writing delivered to the
foregoing attorneys-in-fact.

     IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be
executed as of this 14th day of December, 2020.

/s/Adam Krauss
Adam Krauss